Michael G McDonell1, Jordan Skalisky2, Emily Leickly3, Sterling McPherson4, Samuel Battalio3, Jenny R Nepom2, Debra Srebnik3, John Roll4, Richard K Ries3. 1. Initiative for Research and Education to Advance Community Health (I-REACH), Washington State University, Box 1495, Spokane, WA 99210, United States. Electronic address: mmcdonell@wsu.edu. 2. Initiative for Research and Education to Advance Community Health (I-REACH), Washington State University, Box 1495, Spokane, WA 99210, United States. 3. Harborview Medical Center, Department of Psychiatry and Behavioral Sciences, University of Washington, Box 359911, 325 9th Avenue, Seattle, WA 98195, United States. 4. Program of Excellence in Addictions Research, Washington State University, PO Box 1495, Spokane, WA 99210 and Providence Medical Research Center, Providence Health Care, Spokane, WA 99210, United States.
Abstract
AIMS: This study investigated which ethyl glucuronide immunoassay (EtG-I) cutoff best detects heavy versus light drinking over five days in alcohol dependent outpatients. METHODS: A total of 121 adults with alcohol use disorders and co-occurring psychiatric disorders took part in an alcohol treatment study. Participants provided self-reported drinking data and urine samples three times per week for 16-weeks (total samples=2761). Agreement between low (100 ng/mL, 200 ng/mL), and moderate (500 ng/mL) EtG-I cutoffs and light (women ≤3 standard drinks, men ≤4 standard drinks) and heavy drinking (women >3, men >4 standard drinks) were calculated over one to five days. RESULTS: The 100 ng/mL cutoff detected >76% of light drinking for two days, and 66% at five days. The 100 ng/mL cutoff detected 84% (1 day) to 79% (5 days) of heavy drinking. The 200 ng/mL cutoff detected >55% of light drinking across five days and >66% of heavy drinking across five days. A 500 ng/mL cutoff identified 68% of light drinking and 78% of heavy drinking for one day, with detection of light (2-5 days <58%) and heavy drinking (2-5 days <71%) decreasing thereafter. Relative to 100 ng/mL, the 200 ng/mL and 500 ng/mL cutoffs were less likely to result in false positives. CONCLUSIONS: An EtG-I cutoff of 100 ng/mL is most likely to detect heavy drinking for up to five days and any drinking during the previous two days. Cutoffs of ≥500 ng/mL are likely to only detect heavy drinking during the previous day.
RCT Entities:
AIMS: This study investigated which ethyl glucuronide immunoassay (EtG-I) cutoff best detects heavy versus light drinking over five days in alcohol dependent outpatients. METHODS: A total of 121 adults with alcohol use disorders and co-occurring psychiatric disorders took part in an alcohol treatment study. Participants provided self-reported drinking data and urine samples three times per week for 16-weeks (total samples=2761). Agreement between low (100 ng/mL, 200 ng/mL), and moderate (500 ng/mL) EtG-I cutoffs and light (women ≤3 standard drinks, men ≤4 standard drinks) and heavy drinking (women >3, men >4 standard drinks) were calculated over one to five days. RESULTS: The 100 ng/mL cutoff detected >76% of light drinking for two days, and 66% at five days. The 100 ng/mL cutoff detected 84% (1 day) to 79% (5 days) of heavy drinking. The 200 ng/mL cutoff detected >55% of light drinking across five days and >66% of heavy drinking across five days. A 500 ng/mL cutoff identified 68% of light drinking and 78% of heavy drinking for one day, with detection of light (2-5 days <58%) and heavy drinking (2-5 days <71%) decreasing thereafter. Relative to 100 ng/mL, the 200 ng/mL and 500 ng/mL cutoffs were less likely to result in false positives. CONCLUSIONS: An EtG-I cutoff of 100 ng/mL is most likely to detect heavy drinking for up to five days and any drinking during the previous two days. Cutoffs of ≥500 ng/mL are likely to only detect heavy drinking during the previous day.
Authors: Scott H Stewart; David G Koch; Douglas M Burgess; Ira R Willner; Adrian Reuben Journal: Alcohol Clin Exp Res Date: 2012-06-22 Impact factor: 3.455
Authors: Dennis M Donovan; George E Bigelow; Gregory S Brigham; Kathleen M Carroll; Allan J Cohen; John G Gardin; John A Hamilton; Marilyn A Huestis; John R Hughes; Robert Lindblad; G Alan Marlatt; Kenzie L Preston; Jeffrey A Selzer; Eugene C Somoza; Paul G Wakim; Elizabeth A Wells Journal: Addiction Date: 2011-07-22 Impact factor: 6.526
Authors: Michael G McDonell; Jordan Skalisky; Emily Leickly; Michael F Orr; Sterling McPherson; John Roll; Nathalie Hill-Kapturczak; Martin Javors Journal: Psychol Addict Behav Date: 2017-07-17
Authors: Jeremy C Kane; Sarah M Murray; Michael J Vinikoor; M Claire Greene; Shoshanna L Fine; Ravi Paul; Laura K Murray Journal: Alcohol Clin Exp Res Date: 2019-10-20 Impact factor: 3.455
Authors: Susan E Collins; Seema L Clifasefi; Lonnie A Nelson; Joey Stanton; Silvi C Goldstein; Emily M Taylor; Gail Hoffmann; Victor L King; Alyssa S Hatsukami; Zohar Lev Cunningham; Ellie Taylor; Nigel Mayberry; Daniel K Malone; T Ron Jackson Journal: Int J Drug Policy Date: 2019-03-06
Authors: Michael Gerard McDonell; Emily Leickly; Sterling McPherson; Jordan Skalisky; Katherine Hirchak; Oladunni Oluwoye; Debra Srebnik; John Michael Roll; Richard Kirkland Ries Journal: Am J Addict Date: 2017-08-18
Authors: Emily Leickly; Jordan Skalisky; Sterling McPherson; Michael F Orr; Michael G McDonell Journal: Ther Drug Monit Date: 2017-08 Impact factor: 3.681
Authors: Oladunni Oluwoye; Jordan Skalisky; Ekaterina Burduli; Naomi S Chaytor; Sterling McPherson; Sean M Murphy; Jalene Herron; Katherine Hirchak; Mason Burley; Richard K Ries; John M Roll; Michael G McDonell Journal: Contemp Clin Trials Date: 2018-04-20 Impact factor: 2.226
Authors: Ekaterina Burduli; Jordan Skalisky; Katherine Hirchak; Michael F Orr; Albert Foote; Alexandria Granbois; Richard Ries; John M Roll; Dedra Buchwald; Michael G McDonell; Sterling M McPherson Journal: Clin Trials Date: 2018-08-29 Impact factor: 2.486
Authors: Oladunni Oluwoye; Emily Leickly; Jordan Skalisky; Sterling McPherson; Katherine Hirchak; Debra Srebnik; John M Roll; Richard K Ries; Michael G McDonell Journal: Int J Ment Health Addict Date: 2017-10-31 Impact factor: 3.836
Authors: Michael F Orr; Crystal Lederhos Smith; Myles Finlay; Samantha C Martin; Olivia Brooks; Oladunni A Oluwoye; Emily Leickly; Michael McDonell; Ekaterina Burduli; Celestina Barbosa-Leiker; Matt Layton; John M Roll; Sterling M McPherson Journal: Behav Pharmacol Date: 2018-08 Impact factor: 2.293
Authors: Emily Leickly; Jordan Skalisky; Oladunni Oluwoye; Sterling M McPherson; Debra Srebnik; John M Roll; Richard K Ries; Michael G McDonell Journal: Subst Abus Date: 2017-12-08 Impact factor: 3.716